Brenntag’s share price closed at €60.6 today after a choppy week in which the stock slipped about 6% over seven days. That nervous move contrasts with a Q2 print that put solid earnings power back on the table. Net income reached €179m and basic earnings per share came in at €1.23, both anchored on revenue of €4,263m in a quarter shaped by pricing and mix rather than runaway volumes.
The market is trading the stock as if the story is fragile. The headline from these earnings is about margin quality holding up in a flat volume world, not a business losing its footing.
Is Brenntag at €60.6 a genuine bargain against that €123.02 DCF estimate, or is the rich 24.1x P/E hinting at something you are missing? Compare the implied upside and risk signals in our valuation analysis for Brenntag
Q2 2026 Brenntag Earnings Summary
- Revenue (Q2 2026 vs Q2 2025): €4,263m vs. €3,869.4m (up about 10.2%)
- Net Income (Q2 2026 vs Q2 2025): €179m vs. €42.9m (up about 317.4%)
- Basic EPS (Q2 2026 vs Q2 2025): €1.23 vs. €0.30 (up about 313.9%)
- Trailing 12 Month Net Income (Q2 2026 TTM vs Q2 2025 TTM): €363.7m vs. €423.6m (down about 14.1%)
Prefer clean visuals instead of wading through another dense wall of earnings tables and raw figures for Brenntag? See the company’s full picture in one place, including how valuation ties back to its recent earnings profile, in our company report for Brenntag.
Brenntag’s Bull Case Leans On Structural Self Help
Bulls argue Brenntag can turn cost savings, better use of its network and higher value specialties into sturdier margins as volumes settle. Q2 gives some support to that story. Volumes were broadly flat, yet net income reached €179m on €4,263m of revenue and gross profit margin improved by about 0.6 percentage points. That points to mix and pricing discipline doing some of the heavy lifting instead of a volume rebound.
The Project Brenntag savings program is also hitting early markers. Management reported a cost saving run rate of €41m in Q2, up from €27m in Q1, on the way to a €150m target for 2026 and €200m to €250m for 2027. Better EBITDA conversion in the specialties segment, especially in Material Sciences, aligns with the narrative that higher margin businesses can carry more of the earnings load if Essentials remain more muted.
Access where the surface looks calm but the models start to disagree on Brenntag’s next inflection. See exactly where the consensus breaks across revenue, EPS and free cash flow in the multi year timeline with the analyst estimates for Brenntag.
Brenntag Bears See Cyclical Help, Not Structural Proof
The bearish line on Brenntag is that margins are fragile once temporary pricing and inventory benefits fade, and that rising compliance and operating costs will eat into any upside. Q2 does not fully disprove that. Gross profit margin improved by about 0.6 percentage points and Specialties EBITDA conversion moved higher, yet management openly links part of this to selling lower cost inventory into a higher price market and to geopolitical disruption in the Middle East.
The cost program is progressing, with a €41m run rate in Q2 on the way to a €150m target for 2026. However, personnel expenses rose sharply due to bonus provisions, and restructuring cash outs are still to come. Trailing 12 month net income of €363.7m is below the prior €423.6m. That leaves bears’ concern about earnings quality and cyclical support doing too much of the work only partly addressed.
After rising personnel costs and restructuring cash needs, could Brenntag’s margin story mask deeper balance sheet pressure points? Review our risk analysis for Brenntag which shows 1 important warning sign.Stay Ahead With Simply Wall St
If Brenntag’s mix of margin questions and a €123.02 DCF estimate has caught your attention, register for free with Simply Wall St and add it to your Watchlist to track the share price against fair value and watch for a better entry point. Once you own Brenntag or any other stock, use the Portfolio Command Center to cut through noise and focus on the key developments that matter to your holdings. For longer term thinking and fresh angles on Brenntag, tap into the Community to see how other investors are interpreting the same data. By spotting potential catalysts and risks early, you give yourself a better chance of staying ahead of the market.
Seeking Alternatives Beyond Brenntag Today
Fresh stock ideas can move from quiet to breakout quickly while the data is still under the radar for now. Do not get caught reacting late. Get in early.
- Spot companies with strong balance sheets before momentum really starts to build by scanning the curated list of solid balance sheet and fundamentals stocks (429 results) that screens for financial resilience while it still matters.
- Ride structural themes that could keep flying over multiple cycles by filtering for 90 nuclear energy infrastructure stocks and see which infrastructure stocks are still priced as if nothing has changed.
- Target companies where cash flows already back the AI story rather than hope by reviewing the hand picked 74 profitable AI stocks that aren't just burning cash before these stocks drop off the radar of early movers.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com